Bepotastine Besilate 10 mg

Adult dose

In general, adults are given 10 mg of bepotastine besilate orally twice daily. The dose may be adjusted as appropriate according to age and symptoms.

This medication should not be used in patients with hypersensitivity to any of its components. It should be used with caution in patients with renal or hepatic impairment and in the elderly. Adverse effects on the central nervous system may include drowsiness, lethargy, headache, and dizziness. Gastrointestinal issues such as dry mouth, vomiting, diarrhea, and abdominal pain may occur. Regular blood tests may be necessary due to potential changes in white blood cell counts or elevated liver enzymes. Hypersensitivity reactions such as rash or swelling may occur, so any abnormal symptoms should be reported immediately. Drowsiness may occur, so caution is advised when driving or operating machinery. Patients undergoing long-term steroid therapy should taper their steroid use gradually while initiating this medication. In patients with renal impairment, the blood concentration may rise, so it is advisable to start with a low dose and closely monitor the patient's condition. The safety of this medication in patients with seasonal allergic rhinitis has not been sufficiently studied, so its use should be approached with caution. If there is no efficacy, it is advisable not to continue long-term use. This medication should not be taken with other antihistamines or alcohol. Women who are pregnant or may become pregnant should avoid this medication, and if necessary, it should be taken only after consulting a doctor. Breastfeeding women should also avoid this medication if possible, and if it must be taken, it is recommended to discontinue breastfeeding. The safety of this medication in children has not been sufficiently verified, so caution should be exercised when used. The elderly should take this medication with caution due to potential retention in the body due to renal function decline. When performing allergy testing, this medication may affect test results, so it is recommended not to take it before testing. The tablets should be taken out of the packaging, as swallowing them whole may cause esophageal damage, so care is needed. This medication should be kept out of the reach of children and stored in a cool, dry place below 30 degrees Celsius to avoid moisture.

drowsiness

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It should also be stored at room temperature, ideally between 1 degree and 30 degrees Celsius, to maintain its effectiveness.

Appearance

White film-coated tablet with a score line

Package unit

30 tablets/bottle, 300 tablets/bottle